Home
>
National Drug Code (NDC)
>
Alendronate Sodium
Alendronate Sodium - 0591-3171-04 - (Alendronate Sodium)
Drug Information of Alendronate Sodium
| Product NDC: | 0591-3171 |
| Proprietary Name: | Alendronate Sodium |
| Non Proprietary Name: | Alendronate Sodium |
| Active Ingredient(s): | 35 mg/1 & nbsp; Alendronate Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Alendronate Sodium
| Product NDC: | 0591-3171 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076768 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080804 |
Package Information of Alendronate Sodium
| Package NDC: | 0591-3171-04 |
| Package Description: | 4 TABLET in 1 BLISTER PACK (0591-3171-04) |
NDC Information of Alendronate Sodium
| NDC Code | 0591-3171-04 |
| Proprietary Name | Alendronate Sodium |
| Package Description | 4 TABLET in 1 BLISTER PACK (0591-3171-04) |
| Product NDC | 0591-3171 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Alendronate Sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080804 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | ALENDRONATE SODIUM |
| Strength Number | 35 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
